Glycated Albumin, a Novel Biomarker for Short-Term Functional Outcomes in Acute Ischemic Stroke

Background: There is growing interest in the use of new biomarkers such as glycated albumin (GA), but data are limited in acute ischemic stroke. We explored the impact of GA on short-term functional outcomes as measured using the modified Rankin Scale (mRS) at 3 months compared to glycated hemoglobi...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Yerim, Lee, Sang-Hwa, Kang, Min Kyoung, Kim, Tae Jung, Jeong, Han-Yeong, Lee, Eung-Joon, Bae, Jeonghoon, Jeon, Kipyoung, Nam, Ki-Woong, Yoon, Byung-Woo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8000654/
https://www.ncbi.nlm.nih.gov/pubmed/33800924
http://dx.doi.org/10.3390/brainsci11030337

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8000654/
https://www.ncbi.nlm.nih.gov/pubmed/33800924
http://dx.doi.org/10.3390/brainsci11030337

Ejemplares similares